Cite
MLA Citation
P. LoRusso et al.. “Phase 1 Study of first-in-class dUTPase inhibitor, TAS-114 in combination with capecitabine in patients with advanced solid tumors.” European journal of cancer, vol. 69, n.d., pp. S119–. http://access.bl.uk/ark:/81055/vdc_100039473424.0x000056